Merighi, S.; Nigro, M.; Travagli, A.; Pasquini, S.; Borea, P.A.; Varani, K.; Vincenzi, F.; Gessi, S.
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity? Int. J. Mol. Sci. 2022, 23, 5056.
https://doi.org/10.3390/ijms23095056
AMA Style
Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S.
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity? International Journal of Molecular Sciences. 2022; 23(9):5056.
https://doi.org/10.3390/ijms23095056
Chicago/Turabian Style
Merighi, Stefania, Manuela Nigro, Alessia Travagli, Silvia Pasquini, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, and Stefania Gessi.
2022. "A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?" International Journal of Molecular Sciences 23, no. 9: 5056.
https://doi.org/10.3390/ijms23095056
APA Style
Merighi, S., Nigro, M., Travagli, A., Pasquini, S., Borea, P. A., Varani, K., Vincenzi, F., & Gessi, S.
(2022). A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity? International Journal of Molecular Sciences, 23(9), 5056.
https://doi.org/10.3390/ijms23095056